HumeCare+ Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: GLP-1 weight loss with real-time body-composition tracking to protect muscle
HumeCare+ scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
HumeCare+ is the GLP-1 telehealth program from Hume Health, the body-composition scale company. It pairs clinician-prescribed compounded semaglutide with continuous body-composition tracking via an included Hume Pod device, so you can see whether you are losing fat rather than muscle. Semaglutide is $199/mo and tirzepatide $299/mo, flat at every dose, billed monthly and cancelable anytime, though no price appears on the marketing site until you finish the intake quiz. A coverage page lists 46 states plus DC and care runs through MDI Medical Group PC, but the pharmacy partner is not named.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
HumeCare+ at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- What's included
- Medication · Consult
- Availability
- 46 states + DC
- FDA status
- No FDA warning letter on record
How we scored HumeCare+
Each dimension is scored algorithmically from HumeCare+’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.7/10At $199/mo, HumeCare+ runs about 8% above the $185 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.0/10HumeCare+ offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.2/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.2/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.1/10HumeCare+ is available in 46 states plus DC: all but Alabama, Arkansas, Louisiana, Mississippi.
Support10%
5.7/10HumeCare+ provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this HumeCare+ review
Last checked August 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed availability in 46 states plus DC
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$299/mo across 3 dose/plan tiers (checked September 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with HumeCare+
We walked HumeCare+’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Take a free ~1-minute online assessment.
- 2A protocol is customized based on your results, with a USA clinician on your team.
- 3Medication is delivered to your home.
- No monthly price is shown up front; pricing is revealed only after you complete the assessment.
- The terms define a 90-day results guarantee for first-time GLP-1 users: thirteen weekly Pod weigh-ins, no missed dose logs, any measurable weight loss, and a claim within 14 days, with the consultation fee excluded.
- Subscription can be canceled anytime.
- Advertises free next-day delivery and unlimited 24/7 access to clinicians.
HumeCare+ customer support
- support@humecare.com
GLP-1 medications HumeCare+ offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Flat $199/mo at every dose (anchor price $299); once-weekly injection. Includes medication, provider consultation and the Hume Pod device
Flat $199/mo at every dose (anchor price $299); pill form
Flat $299/mo at every dose (anchor price $399); sold only as the B12 + glycine combination, with no plain tirzepatide line
Ready to get started?
Plans and promotions change often, so check HumeCare+'s current pricing and active discounts before you decide.
What we like
- Pairs compounded semaglutide with continuous body-composition tracking (lose fat, preserve muscle)
- Includes a Hume Pod body-composition device at no extra cost
- $199/mo semaglutide and $299/mo tirzepatide, flat at every dose with no step-up as you titrate
- Backed by Hume Health, an established body-composition scale brand
- Clinician-prescribed and monitored with weekly tracking
Watch-outs
- No price appears on the marketing site; you must finish the intake quiz and give your name before one is quoted
- Tirzepatide is sold only as a B12 + glycine combination, with no plain tirzepatide option
- Pharmacy partner is not named, though the clinical network is now disclosed as MDI Medical Group PC
- A non-refundable clinical consultation fee is charged at enrollment and at each refill, with no amount published
- Shows a LegitScript 'Enterprise Certification Partner' badge that links to no certificate, beside mislabeled regulator logos
HumeCare+: a GLP-1 program sold with a body-composition scale
HumeCare+ is the prescription arm of Hume Health, the company that makes the Hume Pod smart scale. The pitch is that you should watch fat and muscle move, not just the number on the scale, while you take a GLP-1. Every plan pairs compounded semaglutide or tirzepatide with weekly body scans in the Hume app.
What you pay is not on the marketing site: there is no pricing page, and the homepage never shows a dollar figure. The figure appears only inside the sign-up quiz, after it has asked for your name and your email.
How the pricing works, and what stays hidden until you're inside
Once you get past those screens, the funnel lays out three plans on a single page. Semaglutide injections are $199 a month. The oral pill costs the same $199. Tirzepatide, sold only blended with vitamin B12 and glycine, is $299 a month on the same terms. Each card shows a higher struck-through figure with a “SAVE” label beside it, and a timer that reads “Your offer is reserved for”. The countdown is a sales device, not a deadline. The same three prices show to everyone who reaches that page.
The category median for compounded GLP-1 programs is about $185 a month, so HumeCare+ prices above the middle. The plan cards say “Free Shipping • Cancel anytime” and “Final dose and formulation set by your provider based on your personal requirements”. No dose tiers appear on any card, so the monthly number reads as flat. Billing is monthly and renews on its own unless you cancel “at least 48 hours before your next renewal date”, and the terms rule out pro-rated refunds on any prepaid term.
How we get the market median: $185 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 117 programs that publish one.
One more line in the terms deserves a slow read, because the refund math under the guarantee excludes a “clinical consultation fee assessed at enrollment and each refill”, which the terms call non-refundable. The site never states that fee's amount, and the plan cards don't itemize it. Ask support what it is before you pay.
The medications and the dose ladder: what is and isn't published
HumeCare+ sells compounded semaglutide as a once-weekly injection or a daily pill, and compounded tirzepatide only as the B12-and-glycine blend. It does not offer plain tirzepatide, and the funnel has no brand-name Wegovy or Zepbound plan. The quiz frames the choice as “Weekly GLP-1 injection” versus “Daily GLP-1 pill”. A clinician makes the final call.
No milligram ladder is published anywhere. The medication safety page says injections are taken once a week on the same day, and that your protocol “may include an increase in dose every four weeks”. The only dose figure on the site is the vial in the homepage photo, labeled compounded tirzepatide 10 mg per 2 mL. Want your starting dose before you enroll? You'll have to ask.
- Semaglutide injection: $199 a month, taken once weekly.
- Oral semaglutide: the same $199 a month, taken daily.
- Tirzepatide + B12 + glycine: $299 a month; there is no plain tirzepatide line.
- Hume Pod scale: the terms say devices “may be included with certain membership plans”, and the cards never say which plans.
The sign-up quiz: what it asks and where it stops you
The quiz opens with four soft screens: your goal, your gender at birth, and what interests you about the program. Screen five asks for your first and last name. Height, weight, your state, and an email address come next, and only then does the plan page appear. The medical history comes only after you've seen the plans. It covers bariatric surgery, diabetes medications, current prescriptions, and thyroid cancer and pancreatitis history, plus an allergy check tied to the B12 in the compound.
The quiz banner says “2 minute quiz” and the homepage promises one minute. There is no video visit at any point. Physicians in the clinical network review your answers on their own time, and the terms say “Hume does not guarantee that you will be prescribed medication”. If the physician finds you ineligible, the membership fee is refunded automatically, but only after you return the device in its original condition.
Refills run through a questionnaire in the app each cycle. It asks how you'd like to adjust your dose with your next refill, requires a current weight, and warns that your care team “needs a current measurement for your renewal”, so keep stepping on the Pod. If nothing flags, the prescription “will be confirmed and shipped automatically”, and delivery is advertised as free and next-day.
Trust, safety, and the guarantee's fine print
The prescribing side is named, which is more than many compounded programs manage. Hume Health Care LLC calls itself “a technology and administrative services platform only”, the prescriptions come from MDI Medical Group PC, and the app publishes a roster of its licensed prescribers for three states. The compounding pharmacy is not named anywhere. A “WE ARE REGULATED BY” strip shows a PCAB accreditation seal, an obesity-medicine board badge, and a LegitScript “Enterprise Certification Partner” mark. None of the three links to a certificate you can check. There are no FDA warning letters against HumeCare or Hume Health.
State coverage is published on the app's coverage page, which lists 46 states plus Washington, D.C., and marks Alabama, Arkansas, Louisiana, and Mississippi as unavailable. This is a self-pay program with no insurance route, and the terms say Hume “is not enrolled with Medicare, Medicaid, or any insurance program”.
Read the guarantee twice, because the homepage banner says “Lose 10% body weight or get your money back” within six months. The terms describe something narrower: a 90-day results guarantee for first-time GLP-1 users, paid only if you log every dose, complete all 13 weekly Pod weigh-ins, show no measurable loss at all, and file a claim within 14 days. The consultation fee is excluded from that refund, and the banner and the contract are simply not the same promise.
Who should choose HumeCare+, and who should skip it
Choose it if the body-composition data is the point: you want to see fat and muscle move week to week, you like an app-first program, and you're fine paying above the category median for that layer. The named medical group and the published state list are pluses. If coaching matters more to you than tracking data, Vyora Wellness builds 24/7 coaching and nutrition guidance into its flat-priced plans.
Skip it if you want a price before you hand over your name and email. TrimRx, for example, posts its flat starting prices on its homepage. Skip it if you need plain tirzepatide rather than a vitamin blend, if you live in one of the four excluded states, or if you'd rather buy from a program that names its pharmacy. Skip it too if you want a guarantee that works the way the banner reads.
HumeCare+ is a legitimate, above-median compounded GLP-1 program with a different tracking layer and a funnel that makes you work for the price. Go in knowing the $199 figure, and read the terms before you count on the refund. You can see how these factors are weighed in our scoring methodology.
The Bottom Line
HumeCare+ scores highest on state availability and ease of access.
Ready to start with HumeCare+?
From $199/mo. See current pricing and start your free consultation.
HumeCare+ might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to HumeCare+
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Head-to-head
Compare HumeCare+ vs…
HumeCare+ scores7.2/10
Side-by-side pricing, medications and scores. Pick a matchup.
HumeCare+ vs Amazon One Medical
Amazon One Medical scores 8.5/10

HumeCare+ vs Vytora Health
Vytora Health scores 8.4/10

HumeCare+ vs CoreAge Rx
CoreAge Rx scores 8.3/10

HumeCare+ vs Collective
Collective scores 8.3/10

HumeCare+ vs Found
Found scores 8.3/10
HumeCare+ vs EverSlim
EverSlim scores 8.3/10
All 46 HumeCare+ comparisons
- HumeCare+ vs AgelessRx
- HumeCare+ vs altRX
- HumeCare+ vs Belle Health
- HumeCare+ vs bmiMD
- HumeCare+ vs Bodybuilding Health+
- HumeCare+ vs Brightmeds
- HumeCare+ vs Direct Meds
- HumeCare+ vs DudeMeds
- HumeCare+ vs Eden
- HumeCare+ vs Embody
- HumeCare+ vs Enhance MD
- HumeCare+ vs EverPrime
- HumeCare+ vs Gala
- HumeCare+ vs GobyMeds
- HumeCare+ vs HealthRX
- HumeCare+ vs Ivim Health
- HumeCare+ vs Live Vital
- HumeCare+ vs Lttl
- HumeCare+ vs Luvo Health
- HumeCare+ vs MadeMed
- HumeCare+ vs MangoRx
- HumeCare+ vs Maximus
- HumeCare+ vs MEDGm
- HumeCare+ vs MEDVi
- HumeCare+ vs Midi Health
- HumeCare+ vs NewSelf
- HumeCare+ vs Oak
- HumeCare+ vs PlexusDx
- HumeCare+ vs Ro
- HumeCare+ vs RxSpan MD
- HumeCare+ vs Sesame Care
- HumeCare+ vs ShedRx
- HumeCare+ vs SkinnyRx
- HumeCare+ vs SnagRx
- HumeCare+ vs Sprout Health
- HumeCare+ vs Strut Health
- HumeCare+ vs TMates
- HumeCare+ vs TrimRx
- HumeCare+ vs Wellorithm
- HumeCare+ vs YourEra
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this HumeCare+ review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See HumeCare+'s current pricing
Plans from $199/mo. Start your free consultation to check eligibility and today's price.